MedTrace Logo

Effects of Salvinorin A in Healthy Controls

NCT00700596 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2022-04-07

No results posted yet for this study

Summary

This study evaluates the effects of Salvinorin A (SA). SA is the active ingredient of the plant Salvia divinorum that is known to have been used by Mexican Indians as part of religious rituals. The purpose of this project is to understand what people experience when they consume Salvinorin A.

Conditions

  • Healthy

Interventions

DRUG

Salvinorin A

Low dose: Active SA 250μg Medium Dose: Active SA 500μg High Dose: Active SA 750μg

DRUG

Placebo

Control or Placebo SA (30 % ethanolic solution)

Sponsors & Collaborators

  • National Alliance for Research on Schizophrenia and Depression

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Mohini Ranganathan, M.D. · Yale University School of Medicine, Dept of Psychiatry

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-12
Primary Completion
2014-08-22
Completion
2014-08-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700596 on ClinicalTrials.gov